CX3CR1 deficiency aggravates brain white matter injury and affects expression of the CD36/15LO/NR4A1 signal

Wenzhu Wang1, Jingbo Wang2, Qing Tang1

  • 1Department of Integrated Traditional and Western Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Abstract

Insights

CX3CR1 deletion exacerbates white matter injury and cognitive deficits after traumatic brain injury (TBI) in mice. This deficiency increases CD36 and 15LO expression, impairing neurological recovery.

Area of Science:

  • Neuroscience
  • Immunology
  • Traumatic Brain Injury Research

Background:

  • Traumatic brain injury (TBI) can lead to significant white matter damage and long-term neurological deficits.
  • The CX3CR1 receptor and its ligand CX3CL1 play roles in neuroinflammation and microglial function, potentially influencing TBI outcomes.

Purpose of the Study:

  • To investigate the role of CX3CR1 in white matter injury, neurofunction, and recognition following TBI.
  • To examine the impact of CX3CR1 deficiency on the expression of the CD36/15LO/NR4A1 signaling pathway post-TBI.

Main Methods:

  • A controlled cortical impact (CCI) model of TBI was used in CX3CR1-deficient (CX3CR1GFP/GFP), heterozygous (CX3CR1GFP/+), and wild-type mice.
  • White matter integrity was assessed using fractional anisotropy (FA) and diffusion tensor imaging (DTI).
  • Neurobehavioral tests evaluated cognitive and motor functions, while RT-PCR and Western blot analyzed specific gene and protein expressions.

Main Results:

  • CX3CR1 deficiency worsened white matter damage, evidenced by decreased FA and increased lesion volume.
  • Mice lacking CX3CR1 exhibited more severe impairments in forelimb function, spatial recognition, and memory compared to controls.
  • CX3CR1 deficiency led to increased expression of CD36 and 15LO, and altered NR4A1 expression post-TBI.

Conclusions:

  • CX3CR1 deletion significantly enhances white matter injury and neurological deficits after TBI.
  • The absence of CX3CR1 impacts the recovery of nerve function and alters key molecular signaling pathways involved in brain injury.

Related Concept Videos